Cann Group’s Cultivation Plan in Full Swing
Cann announces plans for 34,000 sqm greenhouse operation in Mildura.
Investment
Zelda Therapeutics strikes agreement giving future access to USA
The agreement is with medicinal cannabis company Ilera Healthcare.
BOD Australia expands into Europe
Agreement with Tilman to distribute medicinal cannabis products in Belgium and Luxemburg.
Althea Group releases investor update.
The medicinal cannabis company boasts successful growth and market capture.
AusCann publishes Investor Presentation
Their focus is to get cannabis-based capsule products on the market for the treatment of chronic pain.
ASX companies begin to show revenue from cannabis sales
ASX medical cannabis companies show their financial standing in their recently published half-yearly reports.
BOD Australia expands medicinal cannabis product range.
With the supply of a 1:1 capsule for a clinical trial on Tourette's Syndrome.
Research uncovers targeted pathway for treatment of breast cancer.
Growing evidence of THC as a treatment option for HER2+ breast cancer.
MGC Pharma confirms highest-THC cannabis strain.
MGC Pharmaceuticals (ASX: MXC) (OTC: MGCLF) has announced confirmation that...
AusCann appoints new CEO
AusCann (ASX: AC8) has announced the appointment of Mr Ido...
Page 2 of 2